Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DEWEY

Showing results (411-420 of 460) with videos related to

Pageof 46
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET studyN D Volkow, J S Fowler, J Logan, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 23, 2012
Aquaporin-2 levels in vitro and in vivo are regulated by VACM-1, a cul 5 geneIsabelle P Le, Sarah Schultz, Bradley T Andresen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 31, 1997
Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjectsG S Smith, R Schloesser, J D Brodie, et al.
ACS Chemical Neuroscience|December 31, 2015
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased FashionYan Zhang, Dwight A Williams, Saheem A Zaidi, et al.
Bioorganic Chemistry|May 26, 2024
Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profileRachael Flammia, Boshi Huang, Piyusha P Pagare, et al.
Synapse (New York, N.Y.)|January 1, 1989
Mapping cocaine binding sites in human and baboon brain in vivoJ S Fowler, N D Volkow, A P Wolf, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 1990
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjectsJ Logan, J S Fowler, N D Volkow, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2024
The role of morphine- and fentanyl-induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota-gut-brain axisKaran H Muchhala, Prajkta S Kallurkar, Minho Kang, et al.
Journal of Medicinal Chemistry|December 20, 2022
Structural Alterations of the "Address" Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG ToxicityHongguang Ma, Piyusha P Pagare, Mengchu Li, et al.
European Journal of Pharmacology|March 10, 2001
GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamineM R Gerasimov, W K Schiffer, E L Gardner, et al.
Pageof 46

Showing results (411-420 of 460) with videos related to

Sort By:
Pageof 46
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1995
Carbon-11-cocaine binding compared at subpharmacological and pharmacological doses: a PET studyN D Volkow, J S Fowler, J Logan, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 23, 2012
Aquaporin-2 levels in vitro and in vivo are regulated by VACM-1, a cul 5 geneIsabelle P Le, Sarah Schultz, Bradley T Andresen, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 31, 1997
Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjectsG S Smith, R Schloesser, J D Brodie, et al.
ACS Chemical Neuroscience|December 31, 2015
17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased FashionYan Zhang, Dwight A Williams, Saheem A Zaidi, et al.
Bioorganic Chemistry|May 26, 2024
Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profileRachael Flammia, Boshi Huang, Piyusha P Pagare, et al.
Synapse (New York, N.Y.)|January 1, 1989
Mapping cocaine binding sites in human and baboon brain in vivoJ S Fowler, N D Volkow, A P Wolf, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 1990
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjectsJ Logan, J S Fowler, N D Volkow, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 22, 2024
The role of morphine- and fentanyl-induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota-gut-brain axisKaran H Muchhala, Prajkta S Kallurkar, Minho Kang, et al.
Journal of Medicinal Chemistry|December 20, 2022
Structural Alterations of the "Address" Moiety of NAN Leading to the Discovery of a Novel Opioid Receptor Modulator with Reduced hERG ToxicityHongguang Ma, Piyusha P Pagare, Mengchu Li, et al.
European Journal of Pharmacology|March 10, 2001
GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamineM R Gerasimov, W K Schiffer, E L Gardner, et al.
Pageof 46